146 related articles for article (PubMed ID: 22395262)
1. The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.
Dubé L; Caillon J; Jacqueline C; Bugnon D; Potel G; Asseray N
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2545-7. PubMed ID: 22395262
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW
Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613
[TBL] [Abstract][Full Text] [Related]
3. Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
Potel G; Caillon J; Fantin B; Raza J; Le Gallou F; Lepage JY; Le Conte P; Bugnon D; Baron D; Drugeon H
Antimicrob Agents Chemother; 1991 Jan; 35(1):111-6. PubMed ID: 2014965
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo.
Lefort A; Arthur M; Garry L; Carbon C; Courvalin P; Fantin B
Antimicrob Agents Chemother; 2000 Aug; 44(8):2077-80. PubMed ID: 10898678
[TBL] [Abstract][Full Text] [Related]
5. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
[TBL] [Abstract][Full Text] [Related]
7. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
De Broe ME; Giuliano RA; Verpooten GA
Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
[TBL] [Abstract][Full Text] [Related]
8. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
Agence française de sécurité sanitaire des produits de santé
Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
[No Abstract] [Full Text] [Related]
9. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.
Fantin B; Carbon C
Antimicrob Agents Chemother; 1990 Dec; 34(12):2387-91. PubMed ID: 2128443
[TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A
Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
[TBL] [Abstract][Full Text] [Related]
11. Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.
Potel G; Caillon J; Le Gallou F; Bugnon D; Le Conte P; Raza J; Lepage JY; Baron D; Drugeon H
Antimicrob Agents Chemother; 1992 Apr; 36(4):744-50. PubMed ID: 1503436
[TBL] [Abstract][Full Text] [Related]
12. Penicillin-netilmicin synergism against Streptococcus faecalis.
Korzeniowski OM; Wennersten C; Moellering RC; Sande MA
Antimicrob Agents Chemother; 1978 Mar; 13(3):430-4. PubMed ID: 122522
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
[TBL] [Abstract][Full Text] [Related]
14. Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis: case report and review.
Tam VH; Mckinnon PS; Levine DP; Brandel SM; Rybak MJ
Pharmacotherapy; 2000 Sep; 20(9):1116-9. PubMed ID: 10999505
[TBL] [Abstract][Full Text] [Related]
15. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of aminoglycoside resistance. European data.
Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
[TBL] [Abstract][Full Text] [Related]
17. Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model.
Dubé L; Caillon J; Gras-Le Guen C; Jacqueline C; Kergueris MF; Granry JC; Potel G; Bugnon D
Antimicrob Agents Chemother; 2003 Nov; 47(11):3663-6. PubMed ID: 14576143
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
DiPersio JR; Krafczyk TL
Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
[TBL] [Abstract][Full Text] [Related]
19. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
20. Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model.
Schwank S; Blaser J
Antimicrob Agents Chemother; 1996 Oct; 40(10):2258-61. PubMed ID: 8891125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
